The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABSCI Corporation | COM | 00091E109 | 3,976,000 | 700,000 | SH | OTR | 700,000 | 0 | 0 | ||
Akero Therapeutics Inc | COM | 00973Y108 | 42,354,276 | 1,676,733 | SH | OTR | 1,676,733 | 0 | 0 | ||
Allogene Therapeutics Inc | COM | 019770106 | 17,209,500 | 3,850,000 | SH | OTR | 3,850,000 | 0 | 0 | ||
Amylyx Pharmaceuticals Inc | COM | 03237H101 | 4,260,000 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
AnaptysBio Inc | COM | 032724106 | 29,276,000 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
Apellis Pharmaceuticals Inc | COM | 03753U106 | 101,454,280 | 1,726,000 | SH | OTR | 1,726,000 | 0 | 0 | ||
Arcus Biosciences Inc | COM | 03969F109 | 30,249,536 | 1,602,200 | SH | OTR | 1,602,200 | 0 | 0 | ||
Argenx SE | SPONSORED ADR | 04016X101 | 39,372,000 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
Arvinas Inc | COM | 04335A105 | 25,123,586 | 608,614 | SH | OTR | 608,614 | 0 | 0 | ||
Atara Biotherapeutics Inc | COM | 046513107 | 2,880,100 | 4,150,000 | SH | OTR | 4,150,000 | 0 | 0 | ||
Avidity Biosciences Inc | COM | 05370A108 | 44,082,942 | 1,727,388 | SH | OTR | 1,727,388 | 0 | 0 | ||
Axsome Therapeutics Inc | COM | 05464T104 | 31,920,000 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
BeiGene Ltd | SPONSORED ADR | 07725L102 | 78,195,000 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
BioAtla Inc | COM | 09077B104 | 2,361,034 | 686,347 | SH | OTR | 686,347 | 0 | 0 | ||
Black Diamond Therapeutics I | COM | 09203E105 | 2,565,420 | 506,000 | SH | OTR | 506,000 | 0 | 0 | ||
Boundless Bio Inc | COM | 10170A100 | 10,136,438 | 711,329 | SH | OTR | 711,329 | 0 | 0 | ||
Century Therapeutics Inc | COM | 15673T100 | 7,315,000 | 1,750,000 | SH | OTR | 1,750,000 | 0 | 0 | ||
Cytokinetics Inc | COM NEW | 23282W605 | 147,231,000 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | ||
Day One Biopharmaceuticals I | COM | 23954D109 | 19,657,858 | 1,189,943 | SH | OTR | 1,189,943 | 0 | 0 | ||
DBV Technologies S A | SPONSORED ADR | 23306J101 | 374,550 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
Engene Holdings Inc | COM | 29286M105 | 12,337,905 | 727,900 | SH | OTR | 727,900 | 0 | 0 | ||
Enliven Therapeutics Inc | COM | 29337E102 | 11,809,187 | 671,358 | SH | OTR | 671,358 | 0 | 0 | ||
Fate Therapeutics Inc | COM | 31189P102 | 60,304,779 | 8,215,910 | SH | OTR | 8,215,910 | 0 | 0 | ||
Geron Corp | COM | 374163103 | 19,800,000 | 6,000,000 | SH | OTR | 6,000,000 | 0 | 0 | ||
Ideaya Biosciences Inc | COM | 45166A102 | 96,659,391 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | ||
Immunovant Inc | COM | 45258J102 | 26,655,750 | 825,000 | SH | OTR | 825,000 | 0 | 0 | ||
Iovance Biotherapeutics Inc | COM | 462260100 | 11,115,000 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
iTeos Therapeutics Inc | COM | 46565G104 | 24,607,351 | 1,804,058 | SH | OTR | 1,804,058 | 0 | 0 | ||
Jasper Therapeutics Inc | COM NEW | 471871202 | 10,276,000 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
Kalvista Pharmaceuticals Inc | COM | 483497103 | 18,857,400 | 1,590,000 | SH | OTR | 1,590,000 | 0 | 0 | ||
Kura Oncology Inc | COM | 50127T109 | 21,330,000 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
Direxion SHS ETF TR | DAILY S&P BIOTEC | 25460G716 | 2,551,500 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
Legend Biotech Corp | SPONSORED ADS | 52490G102 | 33,654,000 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
Merus N V | COM | N5749R100 | 85,557,000 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | ||
Milestone Pharmaceuticals In | COM | 59935V107 | 553,123 | 309,007 | SH | OTR | 309,007 | 0 | 0 | ||
Nkarta Inc | COM | 65487U108 | 60,615,454 | 5,607,350 | SH | OTR | 5,607,350 | 0 | 0 | ||
Nuvalent Inc | COM | 670703107 | 84,115,217 | 1,120,192 | SH | OTR | 1,120,192 | 0 | 0 | ||
Nuvation Bio Inc | *W EXP 07/07/202 | 67080N119 | 80,666 | 266,666 | SH | OTR | 266,666 | 0 | 0 | ||
Orchestra Biomed Hldgs Inc | COM | 68572M106 | 1,255,277 | 238,193 | SH | OTR | 238,193 | 0 | 0 | ||
Oric Pharmaceuticals Inc | COM | 68622P109 | 23,822,851 | 1,732,571 | SH | OTR | 1,732,571 | 0 | 0 | ||
Poseida Therapeutics Inc | COM | 73730P108 | 14,275,250 | 4,475,000 | SH | OTR | 4,475,000 | 0 | 0 | ||
Prelude Therapeutics Inc | COM | 74065P101 | 12,173,680 | 2,568,287 | SH | OTR | 2,568,287 | 0 | 0 | ||
Protara Therapeutics Inc | COM STK | 74365U107 | 839,000 | 209,227 | SH | OTR | 209,227 | 0 | 0 | ||
Prothena Corp PLC | SHS | G72800108 | 17,091,300 | 690,000 | SH | OTR | 690,000 | 0 | 0 | ||
Relay Therapeutics Inc | COM | 75943R102 | 15,098,796 | 1,819,132 | SH | OTR | 1,819,132 | 0 | 0 | ||
Revolution Medicines Inc | COM | 76155X100 | 137,927,125 | 4,279,464 | SH | OTR | 4,279,464 | 0 | 0 | ||
Rocket Pharmaceuticals Inc | COM | 77313F106 | 39,495,414 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | ||
Sana Biotechnology Inc | COM | 799566104 | 15,450,000 | 1,545,000 | SH | OTR | 1,545,000 | 0 | 0 | ||
Sarepta Therapeutics Inc | COM | 803607100 | 84,149,000 | 650,000 | SH | OTR | 650,000 | 0 | 0 | ||
Springworks Therapeutics Inc | COM | 85205L107 | 168,408,248 | 3,421,541 | SH | OTR | 3,421,541 | 0 | 0 | ||
Spyre Therapeutics Inc | COM NEW | 00773J202 | 9,482,500 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
Structure Therapeutics Inc | SPONSORED ADS | 86366E106 | 17,144,000 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
Surrozen Inc | *W EXP 08/01/203 | 86889P117 | 2,167 | 66,666 | SH | OTR | 66,666 | 0 | 0 | ||
Tango Therapeutics Inc | COM | 87583X109 | 65,097,217 | 8,198,642 | SH | OTR | 8,198,642 | 0 | 0 | ||
Third Harmonic Bio Inc | COM | 88427A107 | 18,880,000 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
Tyra Biosciences Inc | COM | 90240B106 | 105,753,088 | 6,448,359 | SH | OTR | 6,448,359 | 0 | 0 | ||
Viking Therapeutics Inc | COM | 92686J106 | 24,600,000 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
Xenon Pharmaceuticals Inc | COM | 98420N105 | 25,830,000 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
Zentalis Pharmaceuticals Inc | COM | 98943L107 | 7,092,000 | 450,000 | SH | OTR | 450,000 | 0 | 0 |